Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi

IMPORTANCE: Left ventricular (LV) thrombi can arise in patients with ischemic and nonischemic cardiomyopathies. Anticoagulation is thought to reduce the risk of stroke or systemic embolism (SSE), but there are no high-quality data on the effectiveness of direct oral anticoagulants (DOACs) for this i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Robinson, Austin A., Trankle, Cory R., Eubanks, Grayson, Schumann, Christopher, Thompson, Paul, Wallace, Ryan L., Gottiparthi, Shouri, Ruth, Benjamin, Kramer, Christopher M., Salerno, Michael, Bilchick, Kenneth C., Deen, Cody, Kontos, Michael C., Dent, John
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7177639/
https://ncbi.nlm.nih.gov/pubmed/32320043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.0652
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados